Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism F1F0-ATPase inhibitors(F1F0-ATPase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H35BrN4O6 |
InChIKeyIEDHWPCLYLYTME-PDDLMNHVSA-N |
CAS Registry2332831-92-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mycobacterium Infections, Nontuberculous | Preclinical | SG | 01 Feb 2024 |